Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

Cited In for PubMed (Select 18540923)

1.

Interactions between disordered sleep, post-traumatic stress disorder, and substance use disorders.

Vandrey R, Babson KA, Herrmann ES, Bonn-Miller MO.

Int Rev Psychiatry. 2014 Apr;26(2):237-47. doi: 10.3109/09540261.2014.901300. Review.

2.

Alcohol use disorder: pathophysiology, effects, and pharmacologic options for treatment.

Wackernah RC, Minnick MJ, Clapp P.

Subst Abuse Rehabil. 2014 Jan 23;5:1-12. doi: 10.2147/SAR.S37907. eCollection 2014. Review.

3.

Gabapentin Effect on Pain Associated with Heroin Withdrawal in Iranian Crack: a Randomized Double-blind Clinical Trial.

Behnam B, Semnani V, Saghafi N, Ghorbani R, Dianak Shori M, Ghooshchian Choobmasjedi S.

Iran J Pharm Res. 2012 Summer;11(3):979-83.

4.

Gabapentin treatment for alcohol dependence: a randomized clinical trial.

Mason BJ, Quello S, Goodell V, Shadan F, Kyle M, Begovic A.

JAMA Intern Med. 2014 Jan;174(1):70-7. doi: 10.1001/jamainternmed.2013.11950.

5.
6.

Medications for unhealthy alcohol use: across the spectrum.

O'Malley SS, O'Connor PG.

Alcohol Res Health. 2011;33(4):300-12. Review.

7.

Neurobiology of consummatory behavior: mechanisms underlying overeating and drug use.

Barson JR, Morganstern I, Leibowitz SF.

ILAR J. 2012;53(1):35-58. Review.

8.

Psychiatric disorders and sleep.

Krystal AD.

Neurol Clin. 2012 Nov;30(4):1389-413. doi: 10.1016/j.ncl.2012.08.018. Review.

9.

Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation.

Addolorato G, Leggio L, Hopf FW, Diana M, Bonci A.

Neuropsychopharmacology. 2012 Jan;37(1):163-77. doi: 10.1038/npp.2011.216. Epub 2011 Oct 26. Review.

10.

Kudzu root extract does not perturb the sleep/wake cycle of moderate drinkers.

Bracken BK, Penetar DM, Maclean RR, Lukas SE.

J Altern Complement Med. 2011 Oct;17(10):961-6. doi: 10.1089/acm.2010.0540.

11.

Glutamatergic medications for the treatment of drug and behavioral addictions.

Olive MF, Cleva RM, Kalivas PW, Malcolm RJ.

Pharmacol Biochem Behav. 2012 Feb;100(4):801-10. doi: 10.1016/j.pbb.2011.04.015. Epub 2011 Apr 22. Review.

12.

Gabapentin combined with naltrexone for the treatment of alcohol dependence.

Anton RF, Myrick H, Wright TM, Latham PK, Baros AM, Waid LR, Randall PK.

Am J Psychiatry. 2011 Jul;168(7):709-17. doi: 10.1176/appi.ajp.2011.10101436. Epub 2011 Mar 31.

13.

Cognitive-behavioral therapy for insomnia in alcohol dependent patients: a randomized controlled pilot trial.

Arnedt JT, Conroy DA, Armitage R, Brower KJ.

Behav Res Ther. 2011 Apr;49(4):227-33. doi: 10.1016/j.brat.2011.02.003. Epub 2011 Feb 15.

14.

Sleep homeostasis in alcohol-dependent, depressed and healthy control men.

Brower KJ, Hoffmann R, Conroy DA, Arnedt JT, Armitage R.

Eur Arch Psychiatry Clin Neurosci. 2011 Dec;261(8):559-66. doi: 10.1007/s00406-011-0195-5. Epub 2011 Feb 11.

15.

Medication treatment of different types of alcoholism.

Johnson BA.

Am J Psychiatry. 2010 Jun;167(6):630-9. doi: 10.1176/appi.ajp.2010.08101500. Review.

16.
17.

Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked?

Heilig M, Egli M, Crabbe JC, Becker HC.

Addict Biol. 2010 Apr;15(2):169-84. doi: 10.1111/j.1369-1600.2009.00194.x. Review.

18.

A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal.

Myrick H, Malcolm R, Randall PK, Boyle E, Anton RF, Becker HC, Randall CL.

Alcohol Clin Exp Res. 2009 Sep;33(9):1582-8. doi: 10.1111/j.1530-0277.2009.00986.x. Epub 2009 May 26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk